Adeno-associated virus type 2 VP2 capsid protein is nonessential and can tolerate large peptide insertions at its N terminus - Wikidata - awgldk - TriplyDB

Adeno-associated virus type 2 VP2 capsid protein is nonessential and can tolerate large peptide insertions at its N terminus

Adeno-associated virus type 2 VP2 capsid protein is nonessential and can tolerate large peptide insertions at its N terminus

http://www.wikidata.org/entity/Q24563214

about

Packaging capacity of adeno-associated virus serotypes: impact of larger genomes on infectivity and postentry steps.A viral assembly factor promotes AAV2 capsid formation in the nucleolus Adeno-associated Virus as a Mammalian DNA Vector Structural Insights into Adeno-Associated Virus Serotype 5 BAAV transcytosis requires an interaction with beta-1-4 linked- glucosamine and gp96 Green fluorescent protein-tagged adeno-associated virus particles allow the study of cytosolic and nuclear trafficking.Mutagenesis of adeno-associated virus type 2 capsid protein VP1 uncovers new roles for basic amino acids in trafficking and cell-specific transduction.Gene delivery to mitochondria by targeting modified adenoassociated virus suppresses Leber's hereditary optic neuropathy in a mouse model.Neuronal affinity of a C7C loop peptide identified through phage display.Engineering and selection of shuffled AAV genomes: a new strategy for producing targeted biological nanoparticles.Molecular engineering of viral gene delivery vehicles Directed evolution of adeno-associated virus for glioma cell transduction Heart-targeted adeno-associated viral vectors selected by in vivo biopanning of a random viral display peptide library.AAV's anatomy: roadmap for optimizing vectors for translational success Evidence for the failure of adeno-associated virus serotype 5 to package a viral genome > or = 8.2 kb.Fluorosomes: a convenient new reagent to detect and block multivalent and complex receptor-ligand interactions.The potential of adeno-associated viral vectors for gene delivery to muscle tissue.A NEW RECOMBINANT ADENO-ASSOCIATED VIRUS (AAV)-BASED RANDOM PEPTIDE DISPLAY LIBRARY SYSTEM: INFECTION-DEFECTIVE AAV1.9-3 AS A NOVEL DETARGETED PLATFORM FOR VECTOR EVOLUTION.Synthetic virology: engineering viruses for gene delivery AAV hybrid serotypes: improved vectors for gene delivery Random Insertion of mCherry Into VP3 Domain of Adeno-associated Virus Yields Fluorescent Capsids With no Loss of Infectivity.Immobilization of FLAG-Tagged Recombinant Adeno-Associated Virus 2 onto Tissue Engineering Scaffolds for the Improvement of Transgene Delivery in Cell Transplants.Modeling the step of endosomal escape during cell infection by a nonenveloped virus Controlling AAV Tropism in the Nervous System with Natural and Engineered Capsids.Mutant NADH dehydrogenase subunit 4 gene delivery to mitochondria by targeting sequence-modified adeno-associated virus induces visual loss and optic atrophy in mice Intracellular trafficking of adeno-associated viral vectors.Gene therapy for obesity.Perspective on Adeno-Associated Virus Capsid Modification for Duchenne Muscular Dystrophy Gene Therapy Surface loop dynamics in adeno-associated virus capsid assembly.Synthetic intron improves transduction efficiency of trans-splicing adeno-associated viral vectors.Widespread Central Nervous System Gene Transfer and Silencing After Systemic Delivery of Novel AAV-AS Vector.Recombinant adeno-associated virus transduction and integration.Role of cellular FKBP52 protein in intracellular trafficking of recombinant adeno-associated virus 2 vectors.Bioluminescent virion shells: new tools for quantitation of AAV vector dynamics in cells and live animals.Recombinant adeno-associated virus utilizes host cell nuclear import machinery to enter the nucleus Fluorosomes: fluorescent virus-like nanoparticles that represent a convenient tool to visualize receptor-ligand interactions.Assembly of hybrid bacteriophage Qbeta virus-like particles.Adeno-Associated Virus Gene Therapy for Liver Disease.Development of novel AAV serotype 6 based vectors with selective tropism for human cancer cells.Adeno-Associated Virus (AAV) as a Vector for Gene Therapy.

P2860

Q24533013-EAC533F8-A74A-4326-AD19-0C4076FCB7DB Q24630650-7E55F912-EDC2-4EBC-B936-E6B3B5A2107C Q26782605-76C71BF5-AF5A-4FC0-8D65-2BB1BE367358 Q27679454-1CC84078-C51C-4CDC-A2BA-2D79CC76CA09 Q28748622-04E866CA-BB7D-4A75-9F07-1933CD77500F Q30476153-CC5363BC-FAF1-493D-926B-49ECD95DDE8F Q30495947-280A3076-DBDB-48C7-88B5-CA9FC493646F Q30514129-5B9BE518-A4F0-4DA6-A427-EFF3639B7535 Q33252514-5241591B-F18D-4D3B-A591-769C8E92CC52 Q33337378-C5CB873E-4CF1-4002-9BC2-680ADF5D0046 Q33353795-E5455AB5-1AB4-481D-A5D4-192FC482A09B Q33484220-C8A683D7-54A9-4904-A681-56434C75DBFE Q33555864-3069160A-C193-425B-AAF0-3261EB97DE7B Q33659389-3F3E0AB0-5B97-40D8-B89B-0DC432104323 Q33730469-1B9547D8-E7C0-40AD-81A7-E63E37035DBA Q33890975-3994E1AF-2D90-4457-8C8F-A276958890A7 Q33902499-9A42DB5D-643D-4B92-A73F-8BEA37B867B0 Q33908400-8F088C08-2F08-4CAD-AD54-F4FDEE86DD65 Q34487264-8EAA091F-BCDD-401E-8EF6-431CC2DDF238 Q34619573-0EC62739-C3AD-4140-A7FA-497CBA73C267 Q34694806-EB0B18B3-B579-4F36-94DA-443CA3711865 Q35649962-9199CBE5-ACA2-4AE1-AAD6-7B85CEDDCEFA Q35826748-36D35091-AA9A-47D9-A9E9-F8A58D131EA9 Q35853990-48491F4A-3761-4E21-BD43-8624C5A5CB37 Q36073893-B86725AE-32D0-4F37-98CB-9308F0657F7B Q36097743-EB75B56A-8515-4C9E-99BB-A6BBF12C9820 Q36099461-5A153A1D-78AB-4E3B-96BC-BBF11EC02E19 Q36406869-B97D1412-2F85-4C4C-B376-54DDA357295B Q36673382-1768E6DC-4BD6-442D-B0CD-6DC5E262380E Q36728109-2537EADC-0E51-4E1F-B472-2564989014DA Q36951265-F156CE21-9CC4-4A93-8537-F17DBEBCFFE0 Q36953325-FCC6C1BD-3DDC-40D9-A08C-AC0156DB0FE8 Q37005491-8911A790-4110-4AD3-82E1-717849CC73B7 Q37198468-7674BE3B-0C44-4D60-B373-9D01D31EB7B2 Q37713851-EF532DC9-B7AC-4431-B34D-097ACA88E7BC Q38123692-CDF78D44-7DA8-4586-86EB-92A0BDD18CF1 Q38349472-A7EAFA3D-F1ED-40E6-8756-95E1CBDF65CB Q38789554-5CCCF968-C6B9-4B68-94B7-17725C6D2CEF Q38843995-194C308D-C16A-46C0-B355-8546E091748D Q39409371-F2DF59A2-A401-467E-9014-FA2C32B7C329

P2860

Adeno-associated virus type 2 VP2 capsid protein is nonessential and can tolerate large peptide insertions at its N terminus

http://www.wikidata.org/entity/Q24563214

description

2004 nî lūn-bûn

@nan

2004 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

name

Adeno-associated virus type 2 ...... e insertions at its N terminus

@ast

Adeno-associated virus type 2 ...... e insertions at its N terminus

@en

Adeno-associated virus type 2 ...... e insertions at its N terminus

@nl

type

label

Adeno-associated virus type 2 ...... e insertions at its N terminus

@ast

Adeno-associated virus type 2 ...... e insertions at its N terminus

@en

Adeno-associated virus type 2 ...... e insertions at its N terminus

@nl

prefLabel

Adeno-associated virus type 2 ...... e insertions at its N terminus

@ast

Adeno-associated virus type 2 ...... e insertions at its N terminus

@en

Adeno-associated virus type 2 ...... e insertions at its N terminus

@nl

P1433

Q24563214-DB61F991-A2E5-463C-93CE-9652E23B4CED

P1476

Q24563214-D002D847-F1CC-4D33-9954-CFF251A605EE

P2093

Q24563214-5BD3DC4D-73A8-49E5-85B1-DC04F3E2EF8E

Q24563214-63F4D20A-62BB-44BF-BACE-71CAC405058F

Q24563214-AEB69F6B-AD26-49BB-8324-2694AB14E82D

Q24563214-AF091AEE-04F3-48D8-9D6A-C182A09A4254

Q24563214-D5647413-4C19-4831-8F3B-295B9B004C42

Q24563214-E875637D-E45E-416E-8659-8C325AADD7CC

P2860

Q24563214-0BE77912-FF55-479A-B055-59F4E241866C

Q24563214-0C7BD57A-D5C6-47CA-91B0-72DC72929B88

Q24563214-13AA1BF9-C0AB-4565-A373-F7CEBBA28B5B

Q24563214-14DB3A34-B470-4081-BD52-74A6565970AC

Q24563214-153F09D0-C28A-40CC-990C-815D18D54AE8

Q24563214-1603D6C9-5550-4498-9A93-73B06652FC2A

Q24563214-19AB6D58-248B-4E12-89E6-7D1FFBDE91C8

Q24563214-1A41428C-3065-49C6-ACC3-B9556723F6E9

Q24563214-1EA602CD-0869-45F9-B0D6-0FE4C9963D28

Q24563214-26002D0E-45E7-4D8D-8FDA-62EBAF15E76A

P304

Q24563214-D54C2098-CA93-4509-B0F7-CB85CDAEA9B5

P31

Q24563214-DE1EE894-9668-44FC-9D35-03B55725F1B7

P356

Q24563214-17FCC10F-E56A-4953-BC17-BE74743B4D82

P407

Q24563214-C5556DCA-6328-4C99-B79C-1030436E1283

P433

Q24563214-408878CB-6858-4A4E-811C-9FA23D771F87

P478

Q24563214-26BB8B62-3755-4BC7-93A6-A4A1FC648652

P577

Q24563214-147B41F8-8E9A-4215-8263-E2861C6DC135

P698

Q24563214-899130A6-9B80-4705-A0BB-4F0EF110E44B

P921

Q24563214-A12A2256-47A4-4BB8-AB45-D71CB28A85D2

P932

Q24563214-7DDB4F28-B6D8-4F50-8E65-E891DD803912

P356

JVI.78.12.6595-6609.2004

P1433

Journal of Virology

P1476

Adeno-associated virus type 2 ...... e insertions at its N terminus

@en

P2093

Jeffrey K Harrison

http://www.w3.org/2001/XMLSchema#string

Kenneth H Warrington

http://www.w3.org/2001/XMLSchema#string

Nicholas Muzyczka

http://www.w3.org/2001/XMLSchema#string

Oleg S Gorbatyuk

http://www.w3.org/2001/XMLSchema#string

Sergei Zolotukhin

http://www.w3.org/2001/XMLSchema#string

Shaun R Opie

http://www.w3.org/2001/XMLSchema#string

P2860

Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism.

Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus

Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions

The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy.

Direct mapping of adeno-associated virus capsid proteins B and C: a possible ACG initiation codon

Site-directed mutagenesis of adeno-associated virus type 2 structural protein initiation codons: effects on regulation of synthesis and biological activity

Alternate mRNA splicing is required for synthesis of adeno-associated virus VP1 capsid protein

Monoclonal antibodies against the adeno-associated virus type 2 (AAV-2) capsid: epitope mapping and identification of capsid domains involved in AAV-2-cell interaction and neutralization of AAV-2 infection

Random peptide libraries displayed on adeno-associated virus to select for targeted gene therapy vectors.

In vitro selection of viral vectors with modified tropism: the adeno-associated virus display.

P304

6595-609

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.78.12.6595-6609.2004

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

78

http://www.w3.org/2001/XMLSchema#string

P577

2004-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15163751

http://www.w3.org/2001/XMLSchema#string

P921

P932

416546

http://www.w3.org/2001/XMLSchema#string